Omega-3 fatty acids and the development of cognitive abilities: A review of DHA supplementation studies

CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

Volumn 3, Issue , 2008, Pages

  Cheatham, Carol L ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Attention; Cognition; Docosahexaenoic acid; Memory; Polyunsaturated fatty acids

Indexed keywords

EID: 79959874030     PISSN: None     EISSN: 17498848     Source Type: Journal    
DOI: 10.1079/PAVSNNR20083001     Document Type: Review

References (96)

1. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, Logan RW. Infant cerebral cortex phospholipid fatty-acid composition and diet [see comment]. Lancet 1992;340(8823):810-3.
2. Farquharson J, Jamieson EC, Abbasi KA, Patrick WJ, Logan RW, Cockburn F. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Archives of Disease in Childhood 1995;72(3):198-203.
3. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. American Journal of Clinical Nutrition 1994;60(2):189-94.
4. Hornstra G, Al MD, van Houwelingen AC, Foremanvan Drongelen MM. Essential fatty acids in pregnancy and early human development. European Journal of Obstetrics and Gynecology and Reproductive Biology 1995;61(1):57-62.
5. USDA. Individual Fatty Acid Intakes: Results from the 1995 Continuing Survey of Food Intakes by Individuals. Food Surveys Research Group, Baltimore, 1995.
6. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PRC. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003;38(4):391-8.
7. Thatcher RW. Maturation of the human frontal lobes: physiological evidence for staging. Developmental Neuropsychology 1991;7(3):397-419.
8. Sesma HW, Georgieff MK. The effect of adverse intrauterine and newborn environments on cognitive development: the experiences of premature delivery and diabetes during pregnancy. Development and Psychopathology 2003;15(4):991-1015.
9. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukotrienes and Essential Fatty Acids 2006;75(4-5):259-69.
10. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Human Development 1980;4(2):121-9.
11. Kanazawa A, Miyazawa T, Hirono H, Hayashi M, Fujimoto K. Possible essentially of docosahexaenoic acid in Japanese monkey neonates: occurrence in colostrum and low biosynthetic capacity in neonate brains. Lipids 1991;26(1):53-7.
12. Su HM, Bernardo L, Mirmiran M, Ma XH, Corso TN, Nathanielsz PW, et al. Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatric Research 1999;45(1):87-93.
13. James DK, Stephenson T. Fetal nutrition and growth. In: Chamberlain G, Broughton Pipkin F, editors. Clinical Physiology in Obstetrics, 3rd ed. Blackwell Science Ltd., Oxford; 1998. p. 467-97.
14. Crabtree JT, Gordon MJ, Campbell FM, Dutta-Roy AK. Differential distribution and metabolism of arachidonic acid and docosahexaenoic acid by human placental choriocarcinoma (BeWo) cells. Molecular Cellular Biochemistry 1998;185(1-2):191-8.
15. Haggarty P, Page K, Abramovich DR, Ashton J, Brown D. Long-chain polyunsaturated fatty acid transport across the perfused human placenta. Placenta 1997;18(8):635-42.
16. Al MD, Hornstra G, van der Schouw YT, Bulstra-Ramakers MT, Huisjes HJ. Biochemical EFA status of mothers and their neonates after normal pregnancy. Early Human Development 1990;24(3):239-48.
17. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstetrics and Gynecology 2003;101(3):469-79.
18. Kurlak LO, Stephenson TJ. Plausible explanations for effects of long chain polyunsaturated fatty acids (LCPUFA) on neonates. Archives Disease in Childhood Fetal and Neonatal Edition 1999;80(2):F148-54.
19. Martin RE, Bazan NG. Changing fatty acid content of growth cone lipids prior to synaptogenesis. Journal of Neurochemistry 1992;59(1):318-25.
20. Ahmad A, Murthy M, Greiner RS, Moriguchi T, Salem Jr N. A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus. Nutritional Neuroscience 2002;5(2):103-13.
21. Xu LZ, Sanchez R, Sali A, Heintz N. Ligand specificity of brain lipid-binding protein. Journal of Biological Chemistry 1996;271(40):24711-9.
22. Vaidyanathan VV, Rao KV, Sastry PS. Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. Neuroscience Letters 1994;179(1-2):171-4.
23. Stillwell W, Jenski LJ, Crump FT, Ehringer W. Effect of docosahexaenoic acid on mouse mitochondrial membrane properties. Lipids 1997;32(5):497-506.
24. Coti Bertrand P, O'Kusky JR, Innis SM. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. Journal of Nutrition 2006;136(6):1570-5.
25. Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research 1999;56(6):565-70.
26. Bourre JM, Bonneil M, Clement M, Dumont O, Durand G, Lafont H, et al. Function of dietary polyunsaturated fatty acids in the nervous system. Prostaglandins Leukotrienes and Essential Fatty Acids 1993;48(1):5-15.
27. Chen C, Bazan NG. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins and Other Lipid Mediators 2005;77(1-4):65-76.
28. Salem Jr N, Kim HY, Yergey JA. Docosahexaenoic acid: Membrane function and metabolism. In: Simopoulos AP, Kifer RR, Martin RE, editors. Health Effects of Polyunsaturated Fatty Acids in Seafoods, Academic Press, New York; 1986. p. 263-317.
29. Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behavioural Brain Research 2004;152(1):49-57.
30. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proceedings of the National Academy of Sciences of the United States of America 1986;83(11):4021-5.
31. Fedorova I, Salem Jr N. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukotrienes and Essential Fatty Acids 2006;75(4-5):271-89.
32. Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem Jr N. Cognitive deficits in docosahexaenoic aciddeficient rats. Behavioral Neuroscience 2002;116(6):1022-31.
33. Ahmad A, Momenan R, van Gelderen P, Moriguchi T, Greiner RS, Salem Jr N. Gray and white matter brain volume in aged rats raised on n-3 fatty acid deficient diets. Nutritional Neuroscience 2004;7(1):13-20.
34. Belzung C, Leguisquet AM, Barreau S, Delion-Vancassel S, Chalon S, Durand G. Alpha-linolenic acid deficiency modifies distractibility but not anxiety and locomotion in rats during aging. Journal of Nutrition 1998;128(9):1537-42.
35. Frances H, Coudereau JP, Sandouk P, Clement M, Monier C, Bourre JM. Influence of a dietary alpha-linolenic acid deficiency on learning in the Morris water maze and on the effects of morphine. European Journal of Pharmacology 1996;298(3):217-25.
36. Greiner RS, Moriguchi T, Hutton A, Slotnick BM, Salem Jr N. Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks. Lipids 1999;34 Suppl.:S239-43.
37. Lim SY, Hoshiba J, Moriguchi T, Salem Jr N. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatric Research 2005;58(4):741-8.
38. Moriguchi T, Greiner RS, Salem Jr N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. Journal of Neurochemistry 2000;75(6):2563-73.
39. Salem Jr N, Moriguchi T, Greiner RS, McBride K, Ahmad A, Catalan JN, et al. Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids. Journal of Molecular Neuroscience 2001;16(2-3):299-307; discussion 17-21.
40. Takeuchi T, Fukumoto Y, Harada E. Influence of a dietary n -3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behavioural Brain Research 2002;131(1-2):193-204.
41. Wainwright PE, Huang YS, Coscina DV, Levesque S, McCutcheon D. Brain and behavioral effects of dietary n-3 deficiency in mice: a three generational study. Developmental Psychobiology 1994;27(7):467-87.
42. Greiner RS, Moriguchi T, Slotnick BM, Hutton A, Salem Jr N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiology and Behavior 2001;72(3):379-85.
43. Carrie I, Clement M, De Javel D, Frances H, Bourre JM. Learning deficits in first generation OF1 mice deficient in (n-3) polyunsaturated fatty acids do not result from visual alteration. Neuroscience Letters 1999;266(1):69-72.
44. Yamamoto N, Saitoh M, Moriuchi A, Nomura M, Okuyama H. Effect of dietary alpha-linolenate/linoleate balance on brain lipid compositions and learning ability of rats. Journal of Lipid Research 1987;28(2):144-51.
45. Yamamoto N, Hashimoto A, Takemoto Y, Okuyama H, Nomura M, Kitajima R, et al. Effect of the dietary alpha-linolenate/linoleate balance on lipid compositions and learning ability of rats. II. Discrimination process, extinction process, and glycolipid compositions. Journal of Lipid Research 1988;29(8):1013-21.
46. Lamptey MS, Walker BL. A possible essential role for dietary linolenic acid in the development of the young rat. Journal of Nutrition 1976;106(1):86-93.
47. Wainwright PE, Huang YS, Bulman-Fleming B, Mills DE, Redden P, McCutcheon D. The role of n-3 essential fatty acids in brain and behavioral development: a cross-fostering study in the mouse. Lipids 1991;26(1):37-45.
48. Tanabe Y, Hashimoto M, Sugioka K, Maruyama M, Fujii Y, Hagiwara R, et al. Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clinical and Experimental Pharmacology and Physiology 2004;31(10):700-3.
49. Garcia-Calatayud S, Redondo C, Martin E, Ruiz JI, Garcia-Fuentes M, Sanjurjo P, et al. Brain docosahexaenoic acid status and learning in young rats submitted to dietary long-chain polyunsaturated fatty acid deficiency and supplementation limited to lactation. Pediatric Research 2005;57(5 Pt 1):719-23.
50. Gamoh S, Hashimoto M, Sugioka K, Shahdat Hossain M, Hata N, Misawa Y, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999;93(1):237-41.
51. Moriguchi T, Salem Jr N. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. Journal of Neurochemistry 2003;87(2):297-309.
52. Ikemoto A, Ohishi M, Sato Y, Hata N, Misawa Y, Fujii Y, et al. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. Journal of Lipid Research 2001;42(10):1655-63.
53. Ahmad A, Moriguchi T, Salem N. Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatrics Neurology 2002;26(3):210-8.
54. Jeffrey BG, Weisinger HS, Neuringer M, Mitchell DC. The role of docosahexaenoic acid in retinal function. Lipids 2001;36(9):859-71.
55. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research 2005;24(1):87-138.
56. Wainwright PE, Huang YS, Bulman-Fleming B, Levesque S, McCutcheon D. The effects of dietary fatty acid composition combined with environmental enrichment on brain and behavior in mice. Behavioural Brain Research 1994;60(2):125-36.
57. Simmer K, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants [update of Cochrane Database Syst Rev. 2000;(2):CD000375; PMID: 10796351]. Cochrane Database Systematic Reviews 2004(1):CD000375.
58. Simmer K. Longchain polyunsaturated fatty acid supplementation in infants born at term [update of Cochrane Database Syst Rev. 2000;(2):CD000376; PMID: 10796352]. Cochrane Database Systematic Reviews 2001(4):CD000376.
59. McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 longchain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals [see comment]. American Journal of Clinical Nutrition 2005;82(2):281-95.
60. Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukotrienes and Essential Fatty Acids 2007;76(4):189-203.
61. Crawford M. Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants. American Journal of Clinical Nutrition 2000;71 Suppl. 1:275S-84S.
62. Carlson SE. LCPUFA and functional development of preterm and term infants. In: Bindels JG, Goedhart AC, Visser HK, editors. 10th Nutricia Symposium, Klewer Academic Publishers, Dordrecy, Netherlands; 1996. p. 218-24.
63. Carlson SE, Werkman SH, Peeples JM, Wilson WM. Longchain fatty acids and early visual and cognitive development of preterm infants. European Journal of Clinical Nutrition 1994;48 Suppl. 2:S27-30.
64. Clandinin MT, Van Aerde JE, Merkel KL, Harris CL, Springer MA, Hansen JW, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. Journal of Pediatrics 2005;146(4):461-8.
65. Fang P-C, Kuo H-K, Huang C-B, Ko T-Y, Chen C-C, Chung M-Y. The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants. Chang Gung Medical Journal 2005;28(10):708-15.
66. Fewtrell MS, Abbott RA, Kennedy K, Singhal A, Morley R, Caine E, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. Journal of Pediatrics 2004;144(4):471-9.
67. Fewtrell MS, Morley R, Abbott RA, Singhal A, Isaacs EB, Stephenson T, et al. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants [see comment]. Pediatrics 2002;110(1 Pt 1):73-82.
68. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. British Medical Journal 1998;317(7171):1481-7.
69. O'Connor DL, Hall R, Adamkin D, Auestad N, Castillo M, Connor WE, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001;108(2):359-71.
70. O'Connor DL, Jacobs J, Hall R, Adamkin D, Auestad N, Castillo M, et al. Growth and development of premature infants fed predominantly human milk, predominantly premature infant formula, or a combination of human milk and premature formula. Journal of Pediatric Gastroenterology and Nutrition 2003;37(4):437-46.
71. Werkman SH, Carlson SE. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months. Lipids 1996;31(1):91-7.
72. Bayley N. Bayley Scales of Infant Development-II. Psychological Testing Corporation, New York; 1993.
73. Carlson SE, Werkman SH. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996;31(1):85-90.
74. Agostoni C, Trojan S, Bellu R, Riva E, Giovannini M. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatric Research 1995;38(2):262-6.
75. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of longchain polyunsaturated fatty acids and mental development in term infants. Developmental Medicine and Child Neurology 2000;42(3):174-81.
76. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age [see comment]. Lancet 1998;352(9129):688-91.
77. Ben X-m, Zhou X-y, Zhao W-h, Yu W-l, Pan W, Zhang W-l, et al. Growth and development of term infants fed with milk with long-chain polyunsaturated fatty acid supplementation. Chinese Medical Journal 2004;117(8):1268-70.
78. Bouwstra H, Dijck-Brouwer DA, Boehm G, Boersma ER, Muskiet FA, Hadders-Algra M, et al. Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants. Acta Paediatric 2005;94(1):26-32.
79. Lucas A, Stafford M, Morley R, Abbott R, Stephenson T, MacFadyen U, et al. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial [see comment]. Lancet 1999;354(9194):1948-54.
80. Scott DT, Janowsky JS, Carroll RE, Taylor JA, Auestad N, Montalto MB. Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits? Pediatrics 1998;102(5):E59.
81. Auestad N, Halter R, Hall RT, Blatter M, Bogle ML, Burks W, et al. Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. Pediatrics 2001;108(2):372-81.
82. Makrides M, Neumann MA, Simmer K, Gibson RA. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: a randomized, controlled trial. Pediatrics 2000;105(1 Pt 1):32-8.
83. Koletzko B, Baker S, Cleghorn G, Neto UF, Gopalan S, Hernell O, et al. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group [see comment]. Journal of Pediatric Gastroenterology and Nutrition 2005;41(5):584-99.
84. Willatts P, Forsyth JS. The role of long-chain polyunsaturated fatty acids in infant cognitive development. Prostaglandins Leukotrienes and Essential Fatty Acids 2000;63(1-2):95-100.
85. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M, Willatts P, et al. Influence of long-chain polyunsaturated fatty acids on infant cognitive function. Lipids 1998;33(10):973-80.
86. Colombo J, Kannass KN, Shaddy DJ, Kundurthi S, Maikranz JM, Anderson CJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Development 2004;75(4):1254-67.
87. Oken E, Wright RO, Kleinman KP, Bellinger D, Amarasiriwardena CJ, Hu H, et al. Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort. Environmental Health Perspectives 2005;113(10):1376-80.
88. Judge MP. Impact of maternal docosahexaenoic acid (dha) supplementation in the form of a functional food during pregnancy on infant neurodevelopment: A comparison of vision, memory, temperament and problem-solving abilities: U Connecticut, US; 2006.
89. Singer LT. Randomized clinical trials in infancy: methodologic issues. Seminars in Neonatology 2001;6(5):393-401.
90. Cheatham CL, Colombo J, Carlson SE. N-3 fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations. American Journal of Clinical Nutrition 2006;83 Suppl. 6:1458S-66S.
91. Auestad N, Scott DT, Janowsky JS, Jacobsen C, Carroll RE, Montalto MB, et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 2003;112(3 Pt 1):e177-83.
92. Ghys A, Bakker E, Hornstra G, van den Hout M, Ghys A, Bakker E, et al. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Human Development 2002;69(1-2):83-90.
93. Bakker EC, Ghys AJ, Kester AD, Vles JS, Dubas JS, Blanco CE, et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. European Journal of Clinical Nutrition 2003;57(1):89-95.
94. Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Human Development 2007;83(5):279-84.
95. Birberg-Thornberg U, Karlsson T, Gustafsson PA, Duchen K. Nutrition and theory of mind - The role of polyunsaturated fatty acids (PUFA) in the development of theory of mind. Prostaglandins Leukotrienes and Essential Fatty Acids 2006;75(1):33-41.
96. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA, Helland IB, et al. Maternal supplementation with very-longchain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003;111(1):e39-44.